Contact allergy to oxidized geraniol among Swedish dermatitis patients: A multicentre study by the Swedish Contact Dermatitis Research GroupShow others and affiliations
2018 (English)In: Contact Dermatitis, ISSN 0105-1873, E-ISSN 1600-0536, Vol. 79, no 4, p. 232-238Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Geraniol is a widely used fragrance terpene, and is included in fragrance mix I. Geraniol is prone to autoxidation, forming the skin sensitizers geranial, neral, and geraniol-7-hydroperoxide. Oxidized geraniol has previously been patch tested in 1 clinic, giving 1% to 4.6% positive reactions in consecutive patients when tested at 2% to 11%.
AIM: To compare test reactions to pure and oxidized geraniol, to compare 2 different test concentrations of oxidized geraniol and to investigate the pattern of concomitant reactions to fragrance markers of the baseline series in a multicentre setting.
METHODS: One thousand four hundred and seventy-six consecutive patients referred for patch testing were patch tested with geraniol 6% pet. and oxidized geraniol 6% and 11% pet.
RESULTS: Pure geraniol 6% pet., oxidized geraniol 6% pet. and oxidized geraniol 11% pet. gave 1%, 3% and 8% positive patch test reactions and 0.7%, 3% and 5% doubtful reactions, respectively. Approximately 50% of the patients with doubtful reactions to oxidized geraniol 6% pet. had positive reactions to oxidized geraniol 11% pet.
CONCLUSIONS: Oxidized geraniol 11% pet. provides better detection than oxidized geraniol 6% pet. As most patients reacted only to oxidized geraniol, it is important to explore further whether oxidized geraniol should be included in a baseline patch test series.
Place, publisher, year, edition, pages
Blackwell Publishing, 2018. Vol. 79, no 4, p. 232-238
Keywords [en]
allergic contact dermatitis, autoxidation, fragrance contact allergy, fragrance mix I, geraniol, patch testing, terpenes
National Category
Dermatology and Venereal Diseases
Identifiers
URN: urn:nbn:se:oru:diva-67512DOI: 10.1111/cod.13047ISI: 000443805100006PubMedID: 29926925Scopus ID: 2-s2.0-85052815523OAI: oai:DiVA.org:oru-67512DiVA, id: diva2:1224036
Note
Funding Agency:
Edvard Welanders Stiftelse
2018-06-262018-06-262018-09-25Bibliographically approved